β-Substituted Triphenylphosphonium Chlorides with High Antitumor Activity Prepared by Step by Step Processes
摘要
Abstract
A series of β-substituted N-heterocyclic phosphonium chlorides were prepared under mild stepwise reaction conditions without isolating of intermediate products. They exhibit high activity against two cancer cell lines (M-HeLa and HuTu 80), while having moderate cytotoxicity against normal cell line Wi38, as well as low hemolytic activity. The most active against human cervix epitheloid carcinoma (IC50 = 7.1 µM) and human duodenal adenocarcinoma (IC50 = 13.9 µM) was succinimide derivatives bearing alkyl or bicyclic substituents in heterocyclic core.